(22 days)
No
The description focuses on the mechanical components and function of a blood processing set, with no mention of AI or ML.
Yes
The device is designed to process blood collected during surgical procedures for autotransfusion, specifically involving washing, concentrating, and reinfusion of blood products to the patient, which directly contributes to the treatment and management of the patient's condition.
No
The device is designed for collecting, washing, concentrating, and reinfusing blood products during surgery for autotransfusion, not for diagnosing conditions or diseases.
No
The device description clearly outlines physical components like a rotary separation chamber (bowl) and bags, indicating it is a hardware device, not software-only.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to process blood collected during surgery for autotransfusion (reinfusion back into the same patient). This is a therapeutic procedure, not a diagnostic one.
- Device Description: The device is described as a system for blood collection, washing, concentrating, and reinfusion. These are all steps in a blood processing procedure, not a diagnostic test.
- Lack of Diagnostic Elements: There is no mention of analyzing blood components for diagnostic purposes, detecting diseases, or providing information for diagnosis.
- Performance Studies: The performance studies focus on the device's ability to process blood effectively and safely for reinfusion, not on its diagnostic accuracy.
IVD devices are used to examine specimens (like blood, urine, or tissue) in vitro (outside the body) to provide information for the diagnosis, monitoring, or treatment of a disease or condition. This device's function is to prepare blood for reinfusion into the body, which is a therapeutic action.
N/A
Intended Use / Indications for Use
The device is intended for use with specific Autotransfusion machines which are identified on the primary label. It contains the basic components necessary to nroess blood collected during open heart or other surgical procedures for autotransfusion.
The Preassembled Surgical Wash Set is intended for use with specific Autotransfusion machines which are identified on the primary label. It contains the basic components necessary to process blood collected during open heart or other surgical procedures for autotransfusion.
Product codes (comma separated list FDA assigned to the subject device)
CAC
Device Description
The Preassembled Surgical Wash Set is sterile, non-pyrogenic device designed for blood collection from the operating field or from the extracorporeal circuit, washing, concentrating and reinfusion of the blood products to the patient. The Preassembled Surgical Wash Set is composed of a rotary separation chamber (i.e. bowl) and bags connected with the appropriate the a connectors to fit the intended autotransfusion equipment.
The device may be offered in different configurations based on the specific autotransfusion machine for which it is designed. The basic components and the intended use remain the same.
The device is a modified version of the unmodified device, Preassembled Surgical Wash Set.
The modifications consist of: the removal of the silicone treatment from the inner surface of the bowl; the removal of "Y" adaptor resulting in minor modifications to the configuration of the circuit; a general updating of the labeling.
The modified device has an unchanged intended use, materials (with the exception of the removal of the silicone treatment from the inner surface of the bowl), sterjilization process, operating principles, control mechanisms, and fundamental scientific technology.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
In vitro testing was performed in order to provide the data necessary to demonstrate both the substantial equivalence with the unmodified device and also to comply with safety and effectiveness requirements.
The tests were performed according to internal methods developed by the manufacturer.
Since the main modification to the unmodified device is the removal of silicone treatment from the inner surface of the bowl all the tests were performed on sterile wash sets where only the bowl was aged (accelerated aging up to 3 + 1 years). For comparative purpose the modified and unmodified Preassembled Surgical Wash Sets were compared.
The devices were installed on the proper Autotransfusion machine and were tested according to the autotransfusion procedures used by the equipment for blood processing.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Study Type: Non-clinical and In-vitro testing.
Sample Size: Not specified for non-clinical, for in-vitro testing involved modified and unmodified Preassembled Surgical Wash Sets that were aged.
Key Results:
Non-clinical tests: "Applicable tests were carried out in accordance with the requirements of ISO 10993-1:2003 and the FDA May 1st, 1995 Memorandum on the use of the ISO 10993 stadard for biocompatibility testing of raw materials. The results of the testing met established specifications."
In-vitro tests: "The results of these tests met established specifications."
Overall Conclusion: "The modified Preassembled Surgical Wash Set performs in a manner substantially equivalent to the unmodified Preassembled Surgical Wash Set with respect to biocompatibility and the functional parameters. Additional testing has also demonstrated the effectiveness of production techniques to assure that the device is sterile and nonpyrogenic. In conclusion test result of this study suggests the Preassembled Surgical Wash Set is equivalent to the unmodified Preassembled Surgical Wash Set with respect to device function."
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Preassembled Surgical Wash Set (#K872161), Preassembled Surgical Wash Set for Dideco Electa Autotransfusion System (#K020647), Preassembled Surgical Wash Set for ABMS/Compact Advanced Autotransfusion Equipment (#K982650)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Bowl Set for XTRA Autotransfusion System (#K101586), (#K872159)
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5830 Autotransfusion apparatus.
(a)
Identification. An autotransfusion apparatus is a device used to collect and reinfuse the blood lost by a patient due to surgery or trauma.(b)
Classification. Class II (performance standards).
0
Special 510(k) October 29, 2010
K103202
510(k) SUMMARY
SUBMITTER:
Sorin Group Italia 86, Via Statale 12 Nord 41037 Mirandola (MO) Italy
NOV 2 3 2010
CONTACT PERSON:
Luigi Vecchi · Phone: 39 0535 29811 Fax: 39 0535 25229
October 29, 2010
DATE PREPARED:
DEVICE TRADE NAME: Preassembled Surgical Wash Set
COMMON NAME:
Washing Set for Autotransfusion System
Apparatus, Autotransfusion
UNMODIFIED DEVICE:
CLASSIFICATION NAME:
PREDICATE DEVICE :
Preassembled Surgical Wash Set (#K872161)
Preassembled Surgical Wash Set for Dideco Electa Autotransfusion System (#K020647).
Preassembled Surgical Wash Set for ABMS/Compact Advanced Autotransfusion Equipment (#K982650).
Bowl Set for XTRA Autotransfusion System (#K101586).
DEVICE DESCRIPTION:
The Preassembled Surgical Wash Set is sterile, non-pyrogenic device designed for blood collection from the operating field or from the extracorporeal circuit, washing, concentrating and reinfusion of the blood products to the patient. The Preassembled Surgical Wash Set is composed of a rotary separation chamber (i.e. bowl) and bags connected with the appropriate the a connectors to fit the intended autotransfusion equipment.
The device may be offered in different configurations based on the specific autotransfusion machine for which it is designed. The basic components and the intended use remain the same.
The device is a modified version of the unmodified device, Preassembled Surgical Wash Set.
1
..
The modifications consist of: the removal of the silicone treatment from the inner surface of the bowl; the removal of "Y" adaptor resulting in minor modifications to the configuration of the circuit; a general updating of the labeling.
The modified device has an unchanged intended use, materials (with the exception of the removal of the silicone treatment from the inner surface of the bowl), sterjilization process, operating principles, control mechanisms, and fundamental scientific technology.
INDICATION FOR USE:
The device is intended for use with specific Autotransfusion machines which are identified on the primary label. It contains the basic components necessary to nroess blood collected during open heart or other surgical procedures for autotransfusion.
TECHNOLOGICAL CHARACTERISTICS:
The modified Preassembled Surgical Wash Set has the same operating principles and control mechanisms when compared to the unmodified device.
With the exception of the removal of the silicone treatment, the modified Preassembled Surgical Wash Set utilizes the same materials. Minor changes have been introdumed in the circuit configuration due to the removal of the "Y" adaptor (#K872159) which is an accessory used to connect the wash set to a cardiotomy reservoir.
No change to the intended use has been made as a result of these modifications.
There are no differences in packaging type and material between unmodified and the modified Preassembled Surgical Wash Set.
The Preassembled Surgical Wash Set is ethylene oxide sterilized and has a nonpyrogenic fluid path. It is for single use only.
NON CLINICAL TEST RESULTS:
Applicable tests were carried out in accordance with the requirements of ISO 10993-1:2003 and the FDA May 1st, 1995 Memorandum on the use of the ISO 10993 stadard for biocompatibility testing of raw materials.
The results of the testing met established specifications.
IN VITRO TEST RESULTS:
In vitro testing was performed in order to provide the data necessary to demonstrate both the substantial equivalence with the unmodified device and also to comply with safety and effectiveness requirements.
2
The tests were performed according to internal methods developed by the manufacturer.
Since the main modification to the unmodified device is the removal of silicone treatment from the inner surface of the bowl all the tests were performed on sterile wash sets where only the bowl was aged (accelerated aging up to 3 + 1 years). For comparative purpose the modified and unmodified Preassembled Surgical Wash Sets were compared.
The devices were installed on the proper Autotransfusion machine and were tested according to the autotransfusion procedures used by the equipment for blood processing. The results of these tests met established specifications.
CONCLUSIONS:
The modified Preassembled Surgical Wash Set performs in a manner substantially equivalent to the unmodified Preassembled Surgical Wash Set with respect to biocompatibility and the functional parameters. Additional testing has also demonstrated the effectiveness of production techniques to assure that the device is sterile and nonpyrogenic.
In conclusion test result of this study suggests the Preassembled Surgical Wash Set is equivalent to the unmodified Preassembled Surgical Wash Set with respect to device function.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the caduceus. The logo is black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
PAREXEL Consulting LLC c/o Mr. Barry S. Sall Principal Consultant 195 West Street Waltham, MA 02451
NOV 2 3 2010
Re: K103202
Preassembled Surgical Wash Set Regulation Number: 21 CFR 870.5830 Regulation Name: Autotransfusion Apparatus Regulatory Class: Class II (two) Product Code: CAC Dated: October 29, 2010 Received: November 1, 2010
Dear Mr. Sall:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Barry S. Sall
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical . device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Dunia R. Vahmen
Image /page/4/Picture/7 description: The image shows a black and white close-up of a signature. The signature appears to be stylized and cursive. The signature is on a white background.
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
510(k) Number (if known): K 103202
NOV 2 3 2010
Device Name: Preassembled Surgical Wash Set Indication for Use:
The Preassembled Surgical Wash Set is intended for use with specific Autotransfusion machines which are identified on the primary label. It contains the basic components necessary to process blood collected during open heart or other surgical procedures for autotransfusion.
Prescription Use × (Part 21CFR 801 Subpart D)
Over-the- Counter Use AND/OR (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
una R. balme
(Division Sign-Off) Division of Cardiovascular Devices
510(k) Number_K10 3202
CONFIDENTIAL